“Mechanisms of SETBP1-driven Oncogenesis in Myeloid Leukemia”

“Genetic Inactivation of CD5 in Normal T Cells to Enable Safe and Effective CAR T Cell Immunotherapy for T cell Lymphomas”

“Targeting Survival Mechanisms of Persistent Acute Myeloid Leukemia Cells”

"Depletion of GM-CSF and Myeloid Cells as a Strategy to Enhance The Therapeutic Index After Chimeric Antigen Receptor T (CART) Cell Therapy"

"Rational Prioritization of Drug Combinations to Overcome Resistance to Tazemetostat in Germinal Centre B-cell Lymphoma"

"Molecular Mechanism of CAR Activation in Targeting B Cell Leukemia and Lymphoma"

“Patient-Derived MDS Stem Cells from Pluripotent Stem Cells”

“Immunogenic Chemotherapy and Checkpoint Inhibition for Transformed Diffuse Large B-Cell Lymphoma”

“Targeting Aberrant Levels of the Splicing Factor SF3B1 as a Therapeutic Strategy in High-Risk T-Cell Leukemia"

“Decipher and Target Epigenetic Dependency in Acute Myeloid Leukemia with DNMT3A Mutation”

“Targeting Chaperone-Mediated Autophagy for the Eradication of Acute Myeloid Leukemia”

“Determination of the Clonal Architecture and Functional Impact of Mitochondrial DNA Mutations in Acute Myeloid Leukemia”

“Molecular Definition of Leukemia Cell-of-Origin”

“Identification of Novel Therapeutic Strategies for Acute Myeloid Leukemia Arising from a Myeloproliferative Neoplasm”

“Relevance of KLHL6-mediated Protein Degradation in the Pathogenesis of B-cell Lymphoma”

“Epidermal Growth Factor Regulates MDS Stem Cell Fate”